Journals / Türk Nöroloji Dergisi / 2017 / Cilt: 23 - Sayı: 4

Weight Loss and Fingolimod

Kilo Kaybı ve Fingolimod

Pages
113–114
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

KIYLIOĞLU, N. (2022). Weight Loss and Fingolimod. Türk Nöroloji Dergisi, Cilt: 23 - Sayı: 4, 113–114. https://ajindex.com/articles/636845

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Willis MA, Cohen JA. Fingolimod Therapy for Multiple Sclerosis. Semin Neurol 2013;33:37-44
  2. Quesniaux VF, Menninger K, Kunkler A, Vedrine C, Bernhard M, Hedinger R, Kraus G, Schuurman HJ. The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD. Transpl Immunol 2000;8:177-187
  3. Zhao Z, Choi J, Zhao C, Ma ZA. FTY720 Normalizes Hyperglycemia by Stimulating β-Cell in Vivo Regeneration in db / db Mice through Regulation of Cyclin D3 and p57 KIP2. J Biol Chem 2012;287:5562-5573
  4. Moon MH, Jeong JK, Lee JH, Park YG, Lee YJ, Seol JW, Park SY. Antiobesity activity of a sphingosine 1-phosphate analogue FTY720 observed in adipocytes and obese mouse model. Exp Mol Med 2012;44:603-614
  5. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-1119.